2022
Management of noninfectious scleritis
Abdel-Aty A, Gupta A, Del Priore L, Kombo N. Management of noninfectious scleritis. Therapeutic Advances In Ophthalmology 2022, 14: 25158414211070879. PMID: 35083421, PMCID: PMC8785299, DOI: 10.1177/25158414211070879.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsImmunomodulatory agentsNoninfectious scleritisOral nonsteroidal anti-inflammatory drugsTreatment of scleritisInflammatory eye diseaseInflammatory bowel diseaseSystemic lupus erythematosusUse of steroidsAnti-inflammatory drugsDiffuse anteriorInitial therapyPosterior scleritisSystemic steroidsSystemic illnessSystemic therapyAutoimmune conditionsBowel diseaseLupus erythematosusCalcineurin inhibitorsRheumatoid arthritisUnderlying conditionInfectious conditionsEye diseaseScleritis
2021
Factors affecting the resolution of acute non-infectious anterior scleritis
Abdel-Aty A, Kombo N. Factors affecting the resolution of acute non-infectious anterior scleritis. British Journal Of Ophthalmology 2021, 106: 1672-1677. PMID: 34210671, DOI: 10.1136/bjophthalmol-2021-318808.Peer-Reviewed Original ResearchConceptsNon-steroidal anti-inflammatory drugsSystemic non-steroidal anti-inflammatory drugsNon-infectious anterior scleritisAnterior scleritisHispanic raceNSAID useTumor necrosis factor-alpha inhibitorsNecrosis factor-alpha inhibitorsCox proportionate hazards modelDiffuse anterior scleritisNodular anterior scleritisRecords of patientsFuture prospective studiesDifferent patient groupsAnti-inflammatory drugsAcute scleritisBilateral scleritisNecrotising scleritisSystemic corticosteroidsImmunomodulatory therapyTopical corticosteroidsPatient characteristicsLupus erythematosusLupus diagnosisPatient group